STOCK TITAN

BXP, Inc. 424B Filings

BXP NYSE

Every 424B that BXP, Inc. (BXP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow BXP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BXP filings page.

Rhea-AI Summary

BXP registers up to 152,905 shares of common stock to permit issuance in exchange for specified OP Units of Boston Properties Limited Partnership.

These shares may be issued from time to time if holders of certain OP Units present them for redemption and BXP elects to satisfy redemptions by issuing common stock instead of paying cash. The company will receive no cash proceeds from any such issuances and will acquire additional OP Units in exchange for shares. The one-for-one exchange ratio is subject to adjustment to prevent dilution. The prospectus supplement is dated March 6, 2026 and cites a last reported NYSE sale price of $55.47 per share on March 5, 2026.

Rhea-AI Summary

BXP, Inc. registers up to 13,252,000 shares of common stock that may be issued upon exchange of Boston Properties Limited Partnership’s $1.0 billion aggregate principal amount of 2.00% Exchangeable Senior Notes due 2030.

The prospectus supplement registers shares that selling stockholders could resell from time to time if and when the notes are exchanged; BXP will not receive proceeds from those resales and BPLP may satisfy exchange obligations in cash, shares, or a combination at its election. The shares are listed on the NYSE under the symbol BXP and the supplement cites a March 5, 2026 last reported sale price of $55.47 per share.

Rhea-AI Summary

BXP, Inc. has registered $1,000,000,000 of common stock under a sales agency financing agreement dated March 6, 2026, permitting sales through sales agents, forward sellers/forward purchasers or direct principal purchases.

The program may include privately negotiated block trades and at-the-market transactions on the NYSE; sales may be physically settled, cash settled or net share settled under forward sale agreements. The prospectus discloses commissions up to 2.0% and notes potential dilution, acceleration and REIT tax considerations.